Related Experiment Video

Updated: May 21, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Costs of secondary prevention of stroke by carotid endarterectomy

Carsten Hædersdal1, Mette Posborg Søndergaard, Tom Skyhøj Olsen

  • 1Department of Clinical Physiology, Frederiksberg University Hospital, Frederiksberg, Denmark.

European Neurology
|June 29, 2012
PubMed

Insights

Preventing stroke with carotid endarterectomy (CEA) is costly. Performing CEA within two weeks of an ischemic event significantly reduces costs by approximately two-thirds.

Area of Science:

  • Vascular Surgery
  • Health Economics
  • Neurology

Background:

  • Carotid artery stenosis poses a significant stroke risk.
  • Carotid endarterectomy (CEA) is a key intervention for preventing stroke in high-risk patients.
  • Understanding the economic implications of CEA is crucial for healthcare resource allocation.

Purpose of the Study:

  • To estimate the costs associated with preventing stroke via CEA in Denmark.
  • To evaluate the cost-effectiveness of timely CEA intervention.

Main Methods:

  • Cost analysis based on patients referred for carotid Doppler ultrasound (DUS) in Frederiksberg, Denmark.
  • Inclusion of costs for patient identification, DUS, and CEA procedures.
  • Data collected over an 18-month period (2008-2009).

Main Results:

  • 372 patients with transient ischemic attack (TIA), stroke, or amaurosis fugax were referred for DUS.
  • 12 patients had 50-70% stenosis, and 20 had >70% stenosis; 6 underwent CEA.
  • The cost to prevent one recurrent stroke was EUR 207,675-333,918; this decreased to EUR 63,900-102,744 if CEA was performed within two weeks.

Conclusions:

  • The costs of preventing stroke with CEA are substantial.
  • Performing CEA within two weeks of an ischemic event can reduce costs by approximately two-thirds.
  • Timely intervention is key to improving the cost-effectiveness of CEA for stroke prevention.
Abstract

More Related Videos

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis09:36

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

Related Concept Videos

Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...